CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 1,679 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -80.0% | 1,679 | -69.8% | 0.00% | -100.0% |
| Q1 2023 | $5 | -44.4% | 5,552 | -97.6% | 0.00% | – |
| Q4 2022 | $9 | -100.0% | 227,752 | -1.1% | 0.00% | -100.0% |
| Q3 2022 | $34,000 | +100.0% | 230,252 | +2.1% | 0.00% | +100.0% |
| Q2 2022 | $17,000 | -84.8% | 225,500 | -22.7% | 0.00% | -83.3% |
| Q1 2022 | $112,000 | +86.7% | 291,700 | +130.7% | 0.01% | +100.0% |
| Q4 2021 | $60,000 | -28.6% | 126,416 | -35.5% | 0.00% | -25.0% |
| Q3 2021 | $84,000 | +171.0% | 196,100 | +410.7% | 0.00% | +100.0% |
| Q2 2021 | $31,000 | – | 38,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |